StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Medtronic, Inc. (MDT) PT Raised to $91 at Needham & Company
February 21, 2017 1:38 PM
Needham & Company raised its price target on Medtronic, Inc. (NYSE: MDT) to $91.00 (from $84.00) while maintaining a Buy ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Medtronic, Inc. (MDT) PT Raised to $87 at Oppenheimer Following 3Q Report
February 22, 2017 9:23 AM
Wedbush Maintains Neutral Rating and $85 PT on Medtronic (MDT) Following F3Q17 Results
February 22, 2017 7:52 AM
Medtronic, Inc. (MDT) PT Raised to $88 at Evercore ISI
February 21, 2017 11:50 AM
Medtronic (MDT) Tops Q3 EPS by 1c; Reiterates Outlook
February 21, 2017 6:50 AM
Medtronic Reports Third Quarter Financial Results
February 21, 2017 6:46 AM
Jefferies Reiterates Buy and $88 PT on Medtronic (MDT) Ahead of 3Q17 Report
February 17, 2017 8:41 AM
Medtronic Announces Japanese Regulatory Approval for Micra(TM) Transcatheter Pacing System (TPS)
February 17, 2017 8:01 AM
